Morgan Stanley Issues Pessimistic Forecast for Alexandria Real Estate Equities (NYSE:ARE) Stock Price

Alexandria Real Estate Equities (NYSE:ARE) had its price objective reduced by equities researchers at Morgan Stanley from $54.00 to $53.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the real estate investment trust’s stock. Morgan Stanley’s target price indicates a potential upside of 8.85% from the company’s current price.

Other research analysts have also issued research reports about the stock. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Alexandria Real Estate Equities from $53.00 to $55.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. JPMorgan Chase & Co. decreased their price objective on Alexandria Real Estate Equities from $63.00 to $57.00 and set a “neutral” rating for the company in a report on Tuesday, March 10th. Cantor Fitzgerald lowered their price objective on Alexandria Real Estate Equities from $60.00 to $43.00 and set a “neutral” rating for the company in a research report on Wednesday, April 29th. Evercore set a $55.00 target price on Alexandria Real Estate Equities in a research note on Monday, May 4th. Finally, Royal Bank Of Canada decreased their price target on Alexandria Real Estate Equities from $60.00 to $50.00 and set a “sector perform” rating for the company in a research note on Tuesday, May 5th. Three investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Alexandria Real Estate Equities has a consensus rating of “Hold” and an average price target of $51.23.

Alexandria Real Estate Equities Trading Up 0.7%

ARE opened at $48.69 on Tuesday. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.65. The firm has a market cap of $8.49 billion, a price-to-earnings ratio of -7.77, a PEG ratio of 5.86 and a beta of 1.12. Alexandria Real Estate Equities has a 12 month low of $39.41 and a 12 month high of $88.24. The stock has a fifty day moving average price of $46.08 and a 200-day moving average price of $50.09.

Alexandria Real Estate Equities (NYSE:ARE) last issued its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $1.73 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.73. The company had revenue of $671.02 million for the quarter, compared to the consensus estimate of $684.78 million. Alexandria Real Estate Equities had a negative return on equity of 5.21% and a negative net margin of 36.03%.The firm’s revenue for the quarter was down 11.5% compared to the same quarter last year. During the same quarter last year, the company earned $2.30 earnings per share. Alexandria Real Estate Equities has set its FY 2026 guidance at 6.300-6.500 EPS. As a group, equities research analysts anticipate that Alexandria Real Estate Equities will post 6.4 earnings per share for the current fiscal year.

Insider Transactions at Alexandria Real Estate Equities

In other Alexandria Real Estate Equities news, Chairman Joel S. Marcus bought 7,500 shares of Alexandria Real Estate Equities stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average price of $42.72 per share, with a total value of $320,400.00. Following the completion of the acquisition, the chairman directly owned 587,724 shares in the company, valued at approximately $25,107,569.28. This trade represents a 1.29% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Hallie E. Kuhn sold 536 shares of the business’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $48.20, for a total transaction of $25,835.20. Following the transaction, the executive vice president owned 48,301 shares of the company’s stock, valued at $2,328,108.20. This represents a 1.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.35% of the company’s stock.

Hedge Funds Weigh In On Alexandria Real Estate Equities

Several institutional investors have recently made changes to their positions in ARE. Orographic Financial Advisors LLC acquired a new stake in Alexandria Real Estate Equities during the first quarter valued at $307,000. Bank of America Corp DE grew its position in shares of Alexandria Real Estate Equities by 55.0% during the 1st quarter. Bank of America Corp DE now owns 846,385 shares of the real estate investment trust’s stock valued at $39,289,000 after acquiring an additional 300,201 shares during the period. Janus Henderson Group PLC grew its position in shares of Alexandria Real Estate Equities by 335.8% during the 1st quarter. Janus Henderson Group PLC now owns 72,556 shares of the real estate investment trust’s stock valued at $3,367,000 after acquiring an additional 55,908 shares during the period. Bull Harbor Capital LLC purchased a new position in shares of Alexandria Real Estate Equities in the 1st quarter valued at about $235,000. Finally, Arkadios Wealth Advisors raised its holdings in Alexandria Real Estate Equities by 12.3% in the 1st quarter. Arkadios Wealth Advisors now owns 10,827 shares of the real estate investment trust’s stock worth $503,000 after purchasing an additional 1,182 shares during the period. 96.54% of the stock is owned by hedge funds and other institutional investors.

Alexandria Real Estate Equities Company Profile

Alexandria Real Estate Equities, Inc (NYSE: ARE) is a real estate investment trust specializing in the ownership, development and management of collaborative life science and technology campuses. The company’s properties are designed to support research and innovation by providing specialized laboratory, office and manufacturing space tailored to biotechnology, pharmaceutical, academic and related industries.

Since its founding in 1994, Alexandria has cultivated a diversified portfolio of campuses across leading innovation clusters in North America and Europe.